$1.5M sweet spot round size
Most of their 3 investments are in rounds between $9.1M and $20M
2020
BioVersys AG raised $9.1M on January 5, 2023
Investors: AMR Action Fund
VenatoRx Pharmaceuticals, Inc. raised $34M on April 4, 2022
Investors: Abingworth and AMR Action Fund
Adaptive Phage Therapeutics raised $20M on April 4, 2022
Investors: AMR Action Fund